Search Results

This CBHSQ Data Brief presents findings from the evaluation of the State Targeted Response to the Opioid Crisis Grants (Opioid STR) that describe how funding was used to support peer services for people with or recovering from opioid use disorder (OUD).  The evaluation revealed that most Opioid STR grantees used...

These tables are special analyses that include opioid use (or heroin use and prescription pain reliever misuse) or opioid use disorders as a variable. The NSDUH survey years used, as well as by-demographic group analyses, vary.

This short report uses data from the Drug Abuse Warning Network (DAWN) to examine the emergency department (ED) visits for children aged 1 -5 that involved opioid pain relievers. Hydrocodone (Vicodin, Lortab), oxycodone (OxyContin, Percocet), and codeine are examples of opioid pain relievers; buprenorphine (Suboxone), is an opioid that is...

This national report summarizes key findings from the 2016 National Survey on Drug Use and Health (NSDUH) for indicators of substance use and mental health among people aged 12 years old or older in the civilian, noninstitutionalized population of the United States. Estimates include tobacco use, alcohol use, illicit drug...

This spotlight uses 2002 to 2014 National Survey on Drug Use and Health to examine trends in past year opioid misuse among adults aged 18 or older by age group.

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are...

This spotlight uses the 2015 National Survey on Drug Use and Health to examine the relationship between serious mental illness and past year opioid use among adults aged 18 or older.

This report uses the combined 2007 to 2012 National Surveys on Drug Use and Health (NSDUHs), the 2012 Treatment Episode Data Set (TEDS), and the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS) to examine opioid use and treatment among women of childbearing age (aged 15 to 44).

There has been a significant increase in hospitalizations for opioid misuse in recent years. Using 2010-2014 MarketScan commercial data, this report finds that 40 percent of patients do not receive any follow-up services within 30 days after an opioid-related hospitalization. Only 11 percent of patients received the recommended combination of...

This spotlight uses 2013 The Treatment Episode Data Set (TEDS) to examine substance abuse treatment admissions among veterans and nonveterans. Substance abuse treatment admissions were analyzed for alcohol, heroin, cocaine, marijuana, methamphetamine, and other opioids and synthetics.

Describes emergency department (ED) visits involving the nonmedical use of narcotic pain relievers (opioids) using data from the Drug Abuse Warning Network (DAWN). The drugs most commonly combined with narcotic pain relievers in ED visits; trends for narcotic pain relievers (2005-2011); demographic characteristics of narcotic pain reliever-related visits in 2011...

This report looks at costs for substance use disorder treatment reported in the 2010 National Ambulatory Medical Care Survey. These data include costs for prescriptions for medications and behavioral treatment used to treat alcohol use disorders and opioid use disorders made in office visits to general and family practice physicians...

This short report examines emergency department (ED) visits involving benzodiazepines, which are medications prescribed to relieve symptoms of anxiety, panic attacks and seizures. It looks at the effect of combining benzodiazepines with opioid pain relievers or alcohol, both substances that also depress the central nervous system. The report quantifies the...

This is an National Survey of Substance Abuse Treatment Services (NSSATS) short report. It is about what services are offered by opiod treatment programs in 2012.